General Discussions, page-2

Hi All, I have been researching this stock,
I dont have much experience in healthcare stocks, but this looks like this could have some good potential.

I have few questions if someone could help,

First, can someone please explain from experience in this space what is the likelihood of a deal (license/takeover ) being done after phase 1 or do companies need to see phase 2 data before showing some interest?

Can someone please post some links or past deals in the stroke space in order for me to understand what the landscape looks like. I couldn't find much, hence the request.

Secondly, I dont see this stock having much of a re-rating when it completed its phase 1 (it hit $1 before it completed phase 1). In most cases healthcare stocks should pass their all time highs, I am surprised that this didn't have much of a movement. Any guesses why?

Lastly what is the likelihood of a cap raise ?

Thanks
Aki.